Evidence map›Paper›PMID 24713699›Full record

ArticleThe Journal of biological chemistry2014

Mutations in the BLOC-1 subunits dysbindin and muted generate divergent and dosage-dependent phenotypes.

Jennifer Larimore, Stephanie A Zlatic, Avanti Gokhale, Karine Tornieri, Kaela S Singleton, Ariana P Mullin, Junxia Tang, Konrad Talbot, Victor Faundez

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Genetic dissection of theMolecular biology of the cell · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Jennifer LarimoreFrom the Department of Biology, Agnes Scott College, Decatur, Georgia 30030.
Stephanie A Zlaticthe Department of Cell Biology and.
Avanti Gokhalethe Department of Cell Biology and.
Karine Tornierithe Department of Cell Biology and.
Kaela S SingletonFrom the Department of Biology, Agnes Scott College, Decatur, Georgia 30030.
Ariana P Mullinthe Department of Cell Biology and.
Junxia Tangthe Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania 19104, and.
Konrad Talbotthe Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Victor Faundezthe Department of Cell Biology and the Center for Social Translational Neuroscience Emory University, Atlanta, Georgia 30322, vfaunde@emory.edu.
Emory University · USAgnes Scott College · USCedars-Sinai Medical Center · USUniversity of Pennsylvania · US

Funding

Theta and Gamma Oscillations in Cortical MicrocircuitsP50MH064045 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2001 to 2010
$21.6M
ENNCF - Viral Vector CoreP30NS055077 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2008 to 2018
$6.8M
Udall Parkinson's Disease Center at Emory University: Circuitry to TherapyP50NS071669 · NINDS · EMORY UNIVERSITY · PI WICHMANN, THOMAS · 2010 to 2015
$6.8M
Cellular Mechanisms of Neuronal Metal Transport and ToxicityR01GM077569 · NIGMS · EMORY UNIVERSITY · PI FAUNDEZ, VICTOR · 2006 to 2016
$2.6M
Mechanisms of Endosome Trafficking in NeuronsR01NS042599 · NINDS · EMORY UNIVERSITY · PI FAUNDEZ, VICTOR · 2003 to 2012
$2.5M
Neurobiology of Dysbindin in Schizophrenia and sdy MouseR01MH072880 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ARNOLD, STEVEN E · 2005 to 2008
$1.7M
Mechanisms of Endosome Trafficking in NeuronsR56NS042599 · NINDS · EMORY UNIVERSITY · PI FAUNDEZ, VICTOR · 2008 to 2008
$339k
NIGMS NIH HHS GM077569NIGMS NIH HHS R01 GM077569NIMH NIH HHS P50 MH064045NIMH NIH HHS PP MH064045NIMH NIH HHS R01 MH072880NINDS NIH HHS NS42599NINDS NIH HHS P30 NS055077NINDS NIH HHS P30NS055077NINDS NIH HHS R01 NS042599NINDS NIH HHS R56 NS042599NINDS NIH HHS T32 1P50NS071669
6 · The paper itself

Abstract

Post-mortem analysis has revealed reduced levels of the protein dysbindin in the brains of those suffering from the neurodevelopmental disorder schizophrenia. Consequently, mechanisms controlling the cellular levels of dysbindin and its interacting partners may participate in neurodevelopmental processes impaired in that disorder. To address this question, we studied loss of function mutations in the genes encoding dysbindin and its interacting BLOC-1 subunits. We focused on BLOC-1 mutants affecting synapse composition and function in addition to their established systemic pigmentation, hematological, and lung phenotypes. We tested phenotypic homogeneity and gene dosage effects in the mouse null alleles muted (Bloc1s5(mu/mu)) and dysbindin (Bloc1s8(sdy/sdy)). Transcripts of NMDA receptor subunits and GABAergic interneuron markers, as well as expression of BLOC-1 subunit gene products, were affected differently in the brains of Bloc1s5(mu/mu) and Bloc1s8(sdy/sdy) mice. Unlike Bloc1s8(sdy/sdy), elimination of one or two copies of Bloc1s5 generated indistinguishable pallidin transcript phenotypes. We conclude that monogenic mutations abrogating the expression of a protein complex subunit differentially affect the expression of other complex transcripts and polypeptides as well as their downstream effectors. We propose that the genetic disruption of different subunits of protein complexes and combinations thereof diversifies phenotypic presentation of pathway deficiencies, contributing to the wide phenotypic spectrum and complexity of neurodevelopmental disorders.

Indexed as

MutationPhenotypeAnimalsCarrier ProteinsDysbindinDystrophin-Associated Proteinsgamma-Aminobutyric AcidHippocampusHumansMiceMutant ProteinsNeurotransmitter AgentsPigmentationProtein SubunitsSchizophreniaTranscription, GeneticCarrier ProteinsDTNBP1 protein, humanDtnbp1 protein, mouseDysbindinDystrophin-Associated Proteinsgamma-Aminobutyric AcidMutant Proteinsmuted protein, mouseNeurotransmitter AgentsProtein SubunitsVesicular Transport ProteinsAdaptor ProteinsMouse GeneticsProtein ComplexesSchizophreniaSynapses

Identifiers

PMID24713699
PMCPMC4022895
OpenAlexW2081406198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.